{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:11:59Z","timestamp":1760217119356},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,9,29]],"date-time":"2006-09-29T00:00:00Z","timestamp":1159488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,9,29]],"date-time":"2006-09-29T00:00:00Z","timestamp":1159488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1007\/s00204-006-0153-6","type":"journal-article","created":{"date-parts":[[2006,9,28]],"date-time":"2006-09-28T10:15:10Z","timestamp":1159438510000},"page":"353-359","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning"],"prefix":"10.1007","volume":"81","author":[{"given":"Aharon","family":"Levy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giora","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eran","family":"Gilat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kapon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomit","family":"Dachir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomo","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Herskovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zvi","family":"Teitelbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Raveh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,9,29]]},"reference":[{"key":"153_CR1","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/(SICI)1097-0258(19960715)15:13<1325::AID-SIM233>3.0.CO;2-K","volume":"15","author":"BJR Bailey","year":"1996","unstructured":"Bailey BJR, Brairs GL (1996) Estimation of the surface area of the human body. Stat Med 15:1325\u20131332","journal-title":"Stat Med"},{"key":"153_CR2","first-page":"278","volume":"38","author":"M Behne","year":"1989","unstructured":"Behne M, Janshon G, Asskali F, Forster H (1989) The pharmacokinetics of midazolam following intramuscular administration. Anaesthesist 38:278\u2013274","journal-title":"Anaesthesist"},{"key":"153_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(03)00399-5","volume":"2","author":"A Burton","year":"2003","unstructured":"Burton A (2003) Take your pyridostigmine: that\u2019s an (ethical?) order. Lancet Neurol 2:268","journal-title":"Lancet Neurol"},{"key":"153_CR4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/jama.262.5.649","volume":"262","author":"MA Dunn","year":"1989","unstructured":"Dunn MA, Sidell FR (1989) Progress in medical defense against nerve agents. J Am Med Assoc 262:649\u2013652","journal-title":"J Am Med Assoc"},{"key":"153_CR5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00204-002-0425-8","volume":"77","author":"E Gilat","year":"2003","unstructured":"Gilat E, Goldman M, Lahat E, Levy A, Rabinovitz I, Cohen G, Brandeis R, Amitai G, Alkalai D, Eshel G (2003) Nasal midazolam as a novel anticonvulsive treatment against organophosphate-induced sezure activity in the guinea pig. Arch Toxicol 77:167\u2013172","journal-title":"Arch Toxicol"},{"key":"153_CR6","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/0024-3205(80)90617-7","volume":"26","author":"LW Harris","year":"1980","unstructured":"Harris LW, Stitcher DL, Heyl WC (1980) The effect of pretreatment with carbamates, atropine and mecamylamine on survival and on soman induced alterations in rat and rabbit brain acetylcholine. Life Sci 26:1885\u20131891","journal-title":"Life Sci"},{"key":"153_CR7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/096032719201100613","volume":"11","author":"T Kadar","year":"1992","unstructured":"Kadar T, Cohen G, Sahar R, Alkalai D, Shapira S (1992) Long-term study of brain lesions following soman, in comparison to DFP and metrazol poisoning. Hum Exp Toxicol 11:517\u2013523","journal-title":"Hum Exp Toxicol"},{"key":"153_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/096032719501400304","volume":"14","author":"T Kadar","year":"1995","unstructured":"Kadar T, Shapira S, Cohen G, Sahar R, Alkalay D, Raveh L (1995) Sarin-induced neuropathology in rats. Hum Exp Toxicol 14:252\u2013259","journal-title":"Hum Exp Toxicol"},{"key":"153_CR9","first-page":"675","volume":"20","author":"G Lallement","year":"1999","unstructured":"Lallement G, Baubichon D, Clarencon D, Galonnier M, Peoch M, Carpentier P (1999) Review of the value of gacyclidine (GK-11) as adjuvant medication to conventional treatments of organophospate poisoning: primate experiments mimicking various scenarios of military or terrorist attack by soman. Neurotoxicology 20:675\u2013684","journal-title":"Neurotoxicology"},{"issue":"3","key":"153_CR10","first-page":"182","volume":"7","author":"I Layish","year":"2005","unstructured":"Layish I, Krivoy A, Rotman E, Finkelstein A, Tashma Z, Yehezkelli Y (2005) Pharmacologic prophylaxis against nerve agent poisoning. Isr Med Assoc J 7(3):182\u2013187","journal-title":"Isr Med Assoc J"},{"key":"153_CR11","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1016\/0272-0590(85)90132-0","volume":"5","author":"L Leadbeater","year":"1985","unstructured":"Leadbeater L, Inns RH, Ryland JM (1985) Treatment of poisoning by soman. Fund Appl Toxicol 5:S225\u2013S231","journal-title":"Fund Appl Toxicol"},{"key":"153_CR12","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/jps.2600691132","volume":"69","author":"P Levandoski","year":"1980","unstructured":"Levandoski P, Flanagan T (1980) Use of nitrogen-specific detector for GLC determination of caramiphen in whole blood. J Pharm Sci 69:1353\u20131354","journal-title":"J Pharm Sci"},{"key":"153_CR13","unstructured":"Levy A, Brandeis R, Meshulam Y, Wengier A, Dachir S, Shapira S, Levy D, Treves TA, Mawassi F, Korczyn AD (1993) In: Human and animal studies with transdermal physostigmine in proceedings of medical defense on bioscience review, vol 2. US-AMRDC, Baltimore, pp 615\u2013624"},{"key":"153_CR14","unstructured":"Levy A, Brandeis R, Meshulam Y, Wengier A, Dachir S and Shapira S (1996) In: Transdermal physostigmine and scopolamine: human studies in proceedings of medical defense on bioscience review, vol 1. US-AMRMC, Baltimore, pp 505\u2013516"},{"key":"153_CR15","unstructured":"Levy A, Cohen G, Gilat E, Duvdevani R, Allon N, Shapira S, Dachir S, Grauer E, Meshulam Y, Rabinovitz I, Weissman BA, Brandeis R, Amitai G, Raveh L and Kadar T (2000) Therapeutic versus prophylactic treatment strategies against nerve-agent induced brain injuries. In: Proceedings of medical defense on bioscience review. US-AMRMC, Baltimore, pp 280\u2013290"},{"key":"153_CR16","unstructured":"Levy G (1987) Can animal models be used to explore pharmacodynamics problems of clinical interest. In: Breimer DD, Speiser P (eds) Topics in pharmaceutical sciences. Elsevier, Amsterdam, pp 93\u2013106"},{"issue":"3","key":"153_CR17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/j.1552-4604.1998.tb04420.x","volume":"38","author":"MT Marino","year":"1998","unstructured":"Marino MT, Schuster BG, Brueckner RP, Lin E, Kaminskis A, Lasseter KC (1998) Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humans. J Clin Pharmacol 38(3):227\u2013235","journal-title":"J Clin Pharmacol"},{"key":"153_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s002040050637","volume":"73","author":"JH McDonough","year":"1999","unstructured":"McDonough JH, McMonagle J, Copeland T, Zoeffel D, Shih TM (1999) Comparative evaluation of benzodiazepines for control of soman-induced seizures. Arch Toxicol 73:473\u2013478","journal-title":"Arch Toxicol"},{"key":"153_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/jat.2550150406","volume":"15","author":"Y Meshulam","year":"1995","unstructured":"Meshulam Y, Davidovici R, Wengier A, Levy A (1995) Prophylactic transdermal treatment with physostigmine and scopolamine against soman intoxication in guinea-pigs. J Appl Toxicol 15:263\u2013266","journal-title":"J Appl Toxicol"},{"key":"153_CR20","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1002\/jat.815","volume":"21","author":"Y Meshulam","year":"2001","unstructured":"Meshulam Y, Cohen G, Chapman S, Alkalai D, Levy A (2001) Prophylaxis against organophosphate poisoning by sustained release of scopolamine and physostigmine. J Appl Toxicol 21:S75\u2013S78","journal-title":"J Appl Toxicol"},{"key":"153_CR21","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/jps.2600751104","volume":"75","author":"J Mordenti","year":"1986a","unstructured":"Mordenti J (1986a) Man versus beast: pharmakokinetic scalling in mammals. J Pharm Sci 75:1028\u20131040","journal-title":"J Pharm Sci"},{"key":"153_CR22","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/jps.2600750906","volume":"75","author":"J Mordenti","year":"1986b","unstructured":"Mordenti J (1986b) Dosage regimen design for pharmaceutical studies conducted in animals. J Pham Sci 75:852\u2013857","journal-title":"J Pham Sci"},{"key":"153_CR23","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1248\/cpb.35.718","volume":"35","author":"E Nakashima","year":"1987","unstructured":"Nakashima E, Yokogava K, Ichimura F, Kurata K, Kido H, Yamaguchi N, Yaman T (1987) A physiologically based pharmacokinetic model for biperidin in animals and its extrapolation to humans. Chem Pharm Bull 35:718\u2013725","journal-title":"Chem Pharm Bull"},{"key":"153_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1901\/jeab.1994.61-319","volume":"61","author":"JM Petras","year":"1994","unstructured":"Petras JM (1994) Neurology and neuropathology of soman-induced brain injury: an overview. J Exp Anal Behav 61:319\u2013329","journal-title":"J Exp Anal Behav"},{"key":"153_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0013-9351(69)90006-1","volume":"2","author":"DP Rall","year":"1969","unstructured":"Rall DP (1969) Difficulties in extrapolating the results of toxicity studies in laboratory animals to man. Environ Res 2:360\u2013367","journal-title":"Environ Res"},{"key":"153_CR26","unstructured":"Raveh L, Cohen G, Grauer E, Alkalai D, Chapman S, Kapon Y, Sahar R, Kadar T and Shapira S (1996) Efficacy of prophylactic treatments against sarin poisoning in rats. In: Proceedings of medical defense on bioscience review, vol 1. US-AMRMC, Baltimore, pp 539\u2013547"},{"issue":"4","key":"153_CR27","first-page":"551","volume":"20","author":"L Raveh","year":"1999","unstructured":"Raveh L, Chapman S, Cohen G, Alkalay D, Gilat E, Rabinovitz I, Weissman BA (1999) The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning. Neurotoxicology 20(4):551\u2013560","journal-title":"Neurotoxicology"},{"key":"153_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0161-813X(02)00005-0","volume":"23","author":"L Raveh","year":"2002","unstructured":"Raveh L, Weissman BA, Cohen G, Alkalay D, Rabinovitz I, Sonego H, Brandeis R (2002) Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction. Neurotoxicology 23:7\u201317","journal-title":"Neurotoxicology"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-006-0153-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-006-0153-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-006-0153-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-006-0153-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T19:12:31Z","timestamp":1652814751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-006-0153-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,29]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["153"],"URL":"https:\/\/doi.org\/10.1007\/s00204-006-0153-6","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,29]]},"assertion":[{"value":"7 July 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}